title: Continued dominance of pandemic A(H1N1) 2009 influenza in Victoria, Australia in 2010.
abstract: The 2010 Victorian influenza season was characterized by normal seasonal influenza activity and the dominance of the pandemic A(H1N1) 2009 strain. General Practice Sentinel Surveillance rates peaked at 9.4 ILI cases per 1000 consultations in week 36 for metropolitan practices, and at 10.5 ILI cases per 1000 in the following week for rural practices. Of the 678 ILI cases, 23% were vaccinated, a significantly higher percentage than in previous years. A significantly higher percentage of ILI patients were swabbed in 2010 compared to 2003-2008, but similar to 2009, with a similar percentage being positive for influenza as in previous years. Vaccination rates increased with patient age. Melbourne Medical Deputising Service rates peaked in week 35 at 19.1 ILI cases per 1000 consultations. Of the 1914 cases of influenza notified to the Department of Health, Victoria, 1812 (95%) were influenza A infections - 1001 (55%) pandemic A(H1N1) 2009, 4 (< 1%) A(H3N2) and 807 (45%) not subtyped; 88 (5%) were influenza B; and 14 (< 1%) were influenza A and B co-infections. The World Health Organization Collaborating Centre for Reference and Research on Influenza tested 403 isolates of which 261 were positive for influenza, 250 of which were influenza A and 11 were influenza B. Ninety-two per cent of the influenza A viruses were pandemic A(H1N1) 2009, and following antigenic analysis all of these were found to be similar to the current vaccine strain. Three viruses (0.9%) were found to be oseltamivir resistant due to an H275Y mutation in the neuraminidase gene.
authors.affiliation: Victoria Infectious Diseases Reference Laboratory, North Melbourne, Victoria, Australia .
authors.forename: Kristina
authors.initials: K
authors.lastname: Grant
authors.forename: Lucinda
authors.initials: L
authors.lastname: Franklin
authors.forename: Marlena
authors.initials: M
authors.lastname: Kaczmarek
authors.forename: Aeron
authors.initials: A
authors.lastname: Hurt
authors.forename: Renata
authors.initials: R
authors.lastname: Kostecki
authors.forename: Heath
authors.initials: H
authors.lastname: Kelly
authors.forename: James
authors.initials: J
authors.lastname: Fielding
references.citation: Euro Surveill. 2010 Oct 07;15(40):
references.pmid: 20946757
references.citation: Euro Surveill. 2011 Jun 30;16(26):
references.pmid: 21745444
references.citation: PLoS One. 2010 Sep 07;5(9):e12562
references.pmid: 20830210
references.citation: J Clin Virol. 2003 Jul;27(2):170-9
references.pmid: 12829039
references.citation: Commun Dis Intell. 2000 Dec;24(12):379-83
references.pmid: 11225381
references.citation: Aust N Z J Public Health. 2003;27(4):409-12
references.pmid: 14705303
references.citation: Emerg Infect Dis. 2011 Jul;17(7):1181-7
references.pmid: 21762570
references.citation: Commun Dis Intell Q Rep. 2006;30(3):345-9
references.pmid: 17120488
references.citation: Med J Aust. 2011 Jan 17;194(2):68-72
references.pmid: 21241219
references.citation: Euro Surveill. 2009 Oct 22;14(42):
references.pmid: 19883545
references.citation: Euro Surveill. 2011 Jan 20;16(3):
references.pmid: 21262183
references.citation: N Engl J Med. 2009 Jun 18;360(25):2595-8
references.pmid: 19423872
references.citation: PLoS One. 2009;4(3):e5079
references.pmid: 19333374
references.citation: PLoS One. 2010 Oct 14;5(10):e13211
references.pmid: 20976224
references.citation: Aust N Z J Public Health. 2010 Jun;34(3):228-31
references.pmid: 20618261